Category

Press Releases
View/download as PDF • Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysis• Phase IIIb clinical development of Airsupra was conducted by Avillion under an exclusive clinical co-development agreement with AstraZeneca• Airsupra (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in risk of severe asthma exacerbations in patients with...
Read More
CONTACT
+44 (0)203 764 9530
contact@avillionls.com
footer logo